These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 30122112)

  • 1. Inhibitors of osteoblastogenesis in early human milk and maternal serum: evidence for protective properties of mother's milk on bone.
    Briana DD; Gavrili S; Georgantzi S; Marmarinos A; Voulgaris K; Christou C; Gourgiotis D; Malamitsi-Puchner A
    J Matern Fetal Neonatal Med; 2020 Apr; 33(7):1095-1099. PubMed ID: 30122112
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of glucocorticoid treatment on Wnt signalling antagonists (sclerostin and Dkk-1) and their relationship with bone turnover.
    Gifre L; Ruiz-Gaspà S; Monegal A; Nomdedeu B; Filella X; Guañabens N; Peris P
    Bone; 2013 Nov; 57(1):272-6. PubMed ID: 23981659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in Dkk-1, sclerostin, and RANKL serum levels following discontinuation of long-term denosumab treatment in postmenopausal women.
    Fassio A; Adami G; Benini C; Vantaggiato E; Saag KG; Giollo A; Lippolis I; Viapiana O; Idolazzi L; Orsolini G; Rossini M; Gatti D
    Bone; 2019 Jun; 123():191-195. PubMed ID: 30910600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with serum soluble inhibitors of Wnt-β-catenin signaling (sclerostin and dickkopf-1) in patients undergoing peritoneal dialysis.
    Yamada S; Tsuruya K; Tokumoto M; Yoshida H; Ooboshi H; Kitazono T
    Nephrology (Carlton); 2015 Sep; 20(9):639-45. PubMed ID: 25974190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased Sclerostin, but Not Dickkopf-1 Protein, Is Associated with Elevated Pulse Wave Velocity in Hemodialysis Subjects.
    Stavrinou E; Sarafidis PA; Koumaras C; Loutradis C; Giamalis P; Tziomalos K; Karagiannis A; Papagianni A
    Kidney Blood Press Res; 2019; 44(4):679-689. PubMed ID: 31382263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of recent spinal cord injury on wnt signaling antagonists (sclerostin and dkk-1) and their relationship with bone loss. A 12-month prospective study.
    Gifre L; Vidal J; Carrasco JL; Filella X; Ruiz-Gaspà S; Muxi A; Portell E; Monegal A; Guañabens N; Peris P
    J Bone Miner Res; 2015 Jun; 30(6):1014-21. PubMed ID: 25484108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Wnt-signaling inhibitors DKK-1 and sclerostin in bone fragility associated with Turner syndrome.
    Chiarito M; Piacente L; Chaoul N; Pontrelli P; D'Amato G; Grandone A; Russo G; Street ME; Wasniewska MG; Brunetti G; Faienza MF
    J Endocrinol Invest; 2022 Jun; 45(6):1255-1263. PubMed ID: 35237949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant tamoxifen but not aromatase inhibitor therapy decreases serum levels of the Wnt inhibitor dickkopf-1 while not affecting sclerostin in breast cancer patients.
    Göbel A; Kuhlmann JD; Link T; Wimberger P; Browne AJ; Rauner M; Hofbauer LC; Rachner TD
    Breast Cancer Res Treat; 2017 Aug; 164(3):737-743. PubMed ID: 28526959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum extracellular secreted antagonists of the canonical Wnt/β-catenin signaling pathway in patients with Cushing's syndrome.
    Belaya ZE; Rozhinskaya LY; Melnichenko GA; Solodovnikov AG; Dragunova NV; Iljin AV; Dzeranova LK; Dedov II
    Osteoporos Int; 2013 Aug; 24(8):2191-9. PubMed ID: 23358608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wnt signaling pathway inhibitors, sclerostin and DKK-1, correlate with pain and bone pathology in patients with Gaucher disease.
    Ivanova MM; Dao J; Kasaci N; Friedman A; Noll L; Goker-Alpan O
    Front Endocrinol (Lausanne); 2022; 13():1029130. PubMed ID: 36506070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating Levels of Dickkopf-Related Protein 1 Decrease as Measured GFR Declines and Are Associated with PTH Levels.
    Forster CM; White CA; Turner ME; Norman PA; Ward EC; Hopman WM; Adams MA; Holden RM
    Am J Nephrol; 2020; 51(11):871-880. PubMed ID: 33238271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic Alterations of Wnt Inhibitors in Patients with Prostate Cancer and Bone Metastases.
    Aufderklamm S; Hennenlotter J; Leidenberger P; Rausch S; Hohneder A; Kühs U; Maas M; Schwentner C; Bedke J; Stenzl A; Todenhöfer T
    Dis Markers; 2018; 2018():1874598. PubMed ID: 30116403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between inhibitors of the Wnt signalling pathway (Dickkopf-1(DKK1) and sclerostin), bone mineral density, vascular calcification and arterial stiffness in post-menopausal women.
    Hampson G; Edwards S; Conroy S; Blake GM; Fogelman I; Frost ML
    Bone; 2013 Sep; 56(1):42-7. PubMed ID: 23702386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone Sclerostin and Dickkopf-related protein-1 are positively correlated with bone mineral density, bone microarchitecture, and bone strength in postmenopausal osteoporosis.
    Peng J; Dong Z; Hui Z; Aifei W; Lianfu D; Youjia X
    BMC Musculoskelet Disord; 2021 May; 22(1):480. PubMed ID: 34034718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoid therapy causes contradictory changes of serum Wnt signaling-related molecules in systemic autoimmune diseases.
    Kawazoe M; Kaneko K; Shikano K; Kusunoki N; Nanki T; Kawai S
    Clin Rheumatol; 2018 Aug; 37(8):2169-2178. PubMed ID: 28551822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating Dickkopf-1 and sclerostin in patients with Paget's disease of bone.
    Idolazzi L; Fassio A; Tripi G; Braga V; Viapiana O; Adami G; Rossini M; Gatti D
    Clin Rheumatol; 2017 Apr; 36(4):925-928. PubMed ID: 28054306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in bone formation regulator biomarkers in early axial spondyloarthritis.
    Descamps E; Molto A; Borderie D; Lories R; Richard CM; Pons M; Roux C; Briot K
    Rheumatology (Oxford); 2021 Mar; 60(3):1185-1194. PubMed ID: 32888036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High Sclerostin and Dickkopf-1 (DKK-1) Serum Levels in Children and Adolescents With Type 1 Diabetes Mellitus.
    Faienza MF; Ventura A; Delvecchio M; Fusillo A; Piacente L; Aceto G; Colaianni G; Colucci S; Cavallo L; Grano M; Brunetti G
    J Clin Endocrinol Metab; 2017 Apr; 102(4):1174-1181. PubMed ID: 28388723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sclerostin and Dickkopf-1 in renal osteodystrophy.
    Cejka D; Herberth J; Branscum AJ; Fardo DW; Monier-Faugere MC; Diarra D; Haas M; Malluche HH
    Clin J Am Soc Nephrol; 2011 Apr; 6(4):877-82. PubMed ID: 21164019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of correlation of level of expression of Wnt signaling pathway inhibitors sclerostin and dickkopf-1 with disease activity and severity in rheumatoid arthritis patients.
    Singh A; Gupta MK; Mishra SP
    Drug Discov Ther; 2019; 13(1):22-27. PubMed ID: 30880318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.